Rhinomed (ASX:RNO) Change In Inventory : A$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Change In Inventory?

Rhinomed's change in inventory for the quarter that ended in Jun. 2023 was A$0.00 Mil. It means Rhinomed's inventory stayed the same from Dec. 2022 to Jun. 2023 .

Rhinomed's change in inventory for the fiscal year that ended in Jun. 2023 was A$0.00 Mil. It means Rhinomed's inventory stayed the same from Jun. 2022 to Jun. 2023 .

Rhinomed's Total Inventories for the quarter that ended in Jun. 2023 was A$0.63 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Rhinomed's Days Inventory for the quarter that ended in Jun. 2023 was 226.08.

Inventory Turnover measures how fast the company turns over its inventory within a year. Rhinomed's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.81.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Rhinomed's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.24.

Rhinomed Change In Inventory Historical Data

The historical data trend for Rhinomed's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Change In Inventory Chart

Rhinomed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Inventory

Get a 7-Day Free Trial

Rhinomed Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Rhinomed Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Rhinomed (ASX:RNO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Rhinomed's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.9935	/	0.802	*	365 / 2
	=	226.08

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Rhinomed's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.802	/	0.9935
	=	0.81

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Rhinomed's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.9935	/	4.089
	=	0.24

Rhinomed Change In Inventory Related Terms

Thank you for viewing the detailed overview of Rhinomed's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhinomed (ASX:RNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

RHNMF:USA

Address

132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121

Website

https://www.rhinomed.global

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines